DGRA:LSE:LSE-WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc (USD)

ETF | Others |

Last Closing

USD 42.47

Change

0.00 (0.00)%

Market Cap

USD 0.46B

Volume

1.21K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 636.40B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 330.91B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B

ETFs Containing DGRA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.46% 61% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.46% 60% D- 61% D-
Trailing 12 Months  
Capital Gain 19.31% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.31% 74% C 75% C
Trailing 5 Years  
Capital Gain 82.90% 91% A- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.90% 90% A- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 13.45% 82% B 80% B-
Dividend Return 13.45% 81% B- 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.05% 56% F 70% C-
Risk Adjusted Return 103.01% 98% N/A 98% N/A
Market Capitalization 0.46B 68% D+ 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike